ARCH BIOPARTNERS INCARCH BIOPARTNERS INCARCH BIOPARTNERS INC

ARCH BIOPARTNERS INC

No trades
See on Supercharts

ARCH fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Arch Biopartners, Inc. is a portfolio-based biotechnology company, which engages in the development of technologies that have the potential to make a significant medical or commercial impact. Its technology platforms include AB569 and Borg: Peptide-Solid Surface Interface. The company was founded by Richard Gabriel Muruve and Daniel Muruve on March 4, 1983 and is headquartered in Toronto, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ARCH has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company